A novel adipocytokine, omentin, inhibits monocrotaline-induced pulmonary arterial hypertension in rats

Biochemical and Biophysical Research Communications

Volumn 452, Issue 1, 2014, Pages 142-146

  Kazama, Kyosuke ^a   Okada, Muneyoshi ^a   Yamawaki, Hideyuki ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

Adipokine; Pulmonary hypertension; Vascular biology; Vascular reactivity; Vascular remodeling

Indexed keywords

ACETYLCHOLINE; ADIPOCYTOKINE; MONOCROTALINE; NITROPRUSSIDE SODIUM; OMENTIN; UNCLASSIFIED DRUG; CYTOKINE; LECTIN; OMENTIN PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; HEART RIGHT VENTRICLE HYPERTROPHY; HYPERPLASIA; LUNG ARTERY PRESSURE; LUNG DISEASE; LUNG WEIGHT; MALE; NONHUMAN; PULMONARY ARTERIAL HYPERPLASIA; PULMONARY HYPERTENSION; RAT; VASODILATATION; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; HYPERTENSION, PULMONARY; PHYSIOLOGY; WISTAR RAT;

ANIMALS; CYTOKINES; HYPERTENSION, PULMONARY; LECTINS; MALE; MONOCROTALINE; RATS; RATS, WISTAR;

EID: 84907851133     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.08.070     Document Type: Article

References (27)

1. E. Berghausen, H. Ten Freyhaus, and S. Rosenkranz Targeting of platelet-derived growth factor signaling in pulmonary arterial hypertension Handb. Exp. Pharmacol. 218 2013 381 408
2. H.A. Ghofrani, O. Distler, F. Gerhardt, M. Gorenflo, E. Grunig, W.E. Haefeli, M. Held, M.M. Hoeper, C.M. Kahler, H. Kaemmerer, H. Klose, V. Kollner, B. Kopp, S. Mebus, A. Meyer, O. Miera, D. Pittrow, G. Riemekasten, S. Rosenkranz, D. Schranz, R. Voswinckel, and H. Olschewski Treatment of pulmonary arterial hypertension (PAH): recommendations of the Cologne Consensus Conference 2010 Dtsch. Med. Wochenschr. 135 Suppl. 3 2010 S87 S101
3. R. Souza, O. Sitbon, F. Parent, G. Simonneau, and M. Humbert Long term imatinib treatment in pulmonary arterial hypertension Thorax 61 2006 736
4. H. Watanabe Pharmacological treatment of pulmonary hypertension at a turning point Nihon Yakurigaku Zasshi 143 2014 165 172
5. H. Yamawaki Mechanisms of action of novel adipocytokines on the vascular system Nihon Yakurigaku Zasshi 137 2011 131 135
6. A. Schaffler, M. Neumeier, H. Herfarth, A. Furst, J. Scholmerich, and C. Buchler Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue Biochim. Biophys. Acta 1732 2005 96 102
7. R.Z. Yang, M.J. Lee, H. Hu, J. Pray, H.B. Wu, B.C. Hansen, A.R. Shuldiner, S.K. Fried, J.C. McLenithan, and D.W. Gong Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action Am. J. Physiol. Endocrinol. Metab. 290 2006 E1253 E1261
8. C.M. de Souza Batista, R.Z. Yang, M.J. Lee, N.M. Glynn, D.Z. Yu, J. Pray, K. Ndubuizu, S. Patil, A. Schwartz, M. Kligman, S.K. Fried, D.W. Gong, A.R. Shuldiner, T.I. Pollin, and J.C. McLenithan Omentin plasma levels and gene expression are decreased in obesity Diabetes 56 2007 1655 1661
9. S. Maruyama, R. Shibata, R. Kikuchi, Y. Izumiya, T. Rokutanda, S. Araki, Y. Kataoka, K. Ohashi, H. Daida, S. Kihara, H. Ogawa, T. Murohara, and N. Ouchi Fat-derived factor omentin stimulates endothelial cell function and ischemia-induced revascularization via endothelial nitric oxide synthase-dependent mechanism J. Biol. Chem. 287 2012 408 417
10. Q. Wang, X. Feng, C. Zhou, P. Li, and J. Kang Decreased levels of serum omentin-1 in patients with obstructive sleep apnoea syndrome Ann. Clin. Biochem. 50 2013 230 235
11. H. Yamawaki, J. Kuramoto, S. Kameshima, T. Usui, M. Okada, and Y. Hara Omentin, a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells Biochem. Biophys. Res. Commun. 408 2011 339 343
12. K. Kazama, M. Okada, and H. Yamawaki A novel adipocytokine, omentin, inhibits platelet-derived growth factor-BB-induced vascular smooth muscle cell migration through anti-oxidative mechanism Am. J. Physiol. Heart Circ. Physiol. 306 2014 H1714 H1719
13. H. Yamawaki, N. Tsubaki, M. Mukohda, M. Okada, and Y. Hara Omentin, a novel adipokine, induces vasodilation in rat isolated blood vessels Biochem. Biophys. Res. Commun. 393 2010 668 672
14. K. Kazama, M. Okada, Y. Hara, and H. Yamawaki A novel adipocytokine, omentin, inhibits agonists-induced increases of blood pressure in rats J. Vet. Med. Sci. 75 2013 1029 1034
15. M. Okada, T. Harada, R. Kikuzuki, H. Yamawaki, and Y. Hara Effects of telmisartan on right ventricular remodeling induced by monocrotaline in rats J. Pharmacol. Sci. 111 2009 193 200
16. Y. Yamada, J. Maruyama, E. Zhang, A. Okada, A. Yokochi, H. Sawada, Y. Mitani, T. Hayashi, K. Suzuki, and K. Maruyama Effect of thrombomodulin on the development of monocrotaline-induced pulmonary hypertension J. Anesth. 28 2014 26 33
17. M. Okada, R. Kikuzuki, T. Harada, Y. Hori, H. Yamawaki, and Y. Hara Captopril attenuates matrix metalloproteinase-2 and -9 in monocrotaline-induced right ventricular hypertrophy in rats J. Pharmacol. Sci. 108 2008 487 494
18. M. Mukohda, T. Morita, M. Okada, Y. Hara, and H. Yamawaki Long-term methylglyoxal treatment impairs smooth muscle contractility in organ-cultured rat mesenteric artery Pharmacol. Res. 65 2012 91 99
19. K. Kazama, T. Usui, M. Okada, Y. Hara, and H. Yamawaki Omentin plays an anti-inflammatory role through inhibition of TNF-α-induced superoxide production in vascular smooth muscle cells Eur. J. Pharmacol. 686 2012 116 123
20. I. Diebold, A. Petry, J. Hess, and A. Gorlach The NADPH oxidase subunit NOX4 is a new target gene of the hypoxia-inducible factor-1 Mol. Biol. Cell 21 2010 2087 2096
21. S. Ismail, A. Sturrock, P. Wu, B. Cahill, K. Norman, T. Huecksteadt, K. Sanders, T. Kennedy, and J. Hoidal NOX4 mediates hypoxia-induced proliferation of human pulmonary artery smooth muscle cells: the role of autocrine production of transforming growth factor-{beta}1 and insulin-like growth factor binding protein-3 Am. J. Physiol. Lung Cell. Mol. Physiol. 296 2009 L489 L499
22. F. Veit, O. Pak, B. Egemnazarov, M. Roth, D. Kosanovic, M. Seimetz, N. Sommer, H.A. Ghofrani, W. Seeger, F. Grimminger, R.P. Brandes, R.T. Schermuly, and N. Weissmann Function of NADPH oxidase 1 in pulmonary arterial smooth muscle cells after monocrotaline-induced pulmonary vascular remodeling Antioxid. Redox Signal. 19 2013 2213 2231
23. S. Wedgwood, S. Lakshminrusimha, K.N. Farrow, L. Czech, S.F. Gugino, F. Soares, J.A. Russell, and R.H. Steinhorn Apocynin improves oxygenation and increases eNOS in persistent pulmonary hypertension of the newborn Am. J. Physiol. Lung Cell. Mol. Physiol. 302 2012 L616 L626
24. R. Shibata, N. Ouchi, R. Takahashi, Y. Terakura, K. Ohashi, N. Ikeda, A. Higuchi, H. Terasaki, S. Kihara, and T. Murohara Omentin as a novel biomarker of metabolic risk factors Diabetol. Metab. Syndr. 4 2012 37
25. B.K. Tan, R. Adya, S. Farhatullah, K.C. Lewandowski, P. O'Hare, H. Lehnert, and H.S. Randeva Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome: ex vivo and in vivo regulation of omentin-1 by insulin and glucose Diabetes 57 2008 801 808
26. M.L. Alonso-Alvarez, J.A. Cordero-Guevara, J. Teran-Santos, M. Gonzalez-Martinez, M.J. Jurado-Luque, J. Corral-Penafiel, J. Duran-Cantolla, L. Kheirandish-Gozal, and D. Gozal Obstructive sleep apnea in obese community-dwelling children: the NANOS study Sleep 37 2014 943 949
27. R. Summer, K. Walsh, and B.D. Medoff Obesity and pulmonary arterial hypertension: is adiponectin the molecular link between these conditions? Pulm. Circ. 1 2011 440 447